eNeura has been granted a CE mark label extension for its SpringTMS to include migraine prevention.
The device uses single-pulse transcranial magnetic stimulation for the acute and preventive treatment of migraine.
The extended label adds to the device’s existing CE marking for acute treatment of migraines. The device also holds FDA clearance for the same indication. — Anisa Jibrell